Assessing the functional impact of protein binding site definition

Area of Science:

• Biochemistry
• Structural Biology
• Computational Biology

Background:

• Accurate definition of protein binding interfaces is essential for various biomedical applications, including classification of binding specificities and bioengineering.
• Current methods for defining protein interfaces can yield substantially different results, impacting downstream applications.
• Experimental validation through residue mutation is common but introduces unknown alterations to the binding interface.

Approach:

• This study investigates the effect of alternative binding site definitions on protein-ligand recognition.
• A pharmacophore-based approach is employed to evaluate interface definitions without experimentally altering the protein structure.
• The research aims to provide a quantitative understanding of the minimum accuracy required for interface definitions to reflect biological function.

Key Points:

• Different methods for defining protein binding interfaces can lead to significant variations in identified residues.
• The pharmacophore approach allows for the assessment of binding site definition impact without physical mutation.
• Understanding the sensitivity of protein function to interface definition accuracy is critical.

Conclusions:

• The choice of binding interface definition method can influence the perceived ability of a protein to recognize its ligand.
• A pharmacophore approach offers a non-invasive way to study the impact of interface definition on protein function.
• This work establishes guidelines for the minimum accuracy needed in protein interface definition to ensure biological relevance.